GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours

There is no consensus as to the management of untreated poor prognosis or relapsed/refractory germ cell tumours. We have studied an intensive cisplatin-based regimen that incorporates high-dose methotrexate (HD MTX) and actinomycin-D and etoposide every 14 days (GAMEC). Sixty-two patients were enrol...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Shamash, J, Powles, T, Ansell, W, Stebbing, J, Mutsvangwa, K, Wilson, P, Asterling, S, Liu, S, Wyatt, P, Joel, S P, Oliver, R T D
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2007
Teme:
Translational Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360316/
https://ncbi.nlm.nih.gov/pubmed/17609665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603865
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki